Senior Director, Pharmaceutical Operations
La Jolla Pharmaceutical Company is a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies intended to significantly improve outcomes in patients suffering from life-threatening diseases. The Company has several product candidates in development. LJPC-501 is La JollaUas proprietary formulation of angiotensin II for the potential treatment of catecholamine-resistant hypotension.
Product Development with Quality and Regulatory Emphasis • Drug Substance/API: CMO Management for Process Development, GMP Manufacturing, MIP • Drug Product: CMO Management for Formulation Development, Method Transfer, Site Transfer, GMP Manufacturing • Quality: GXP Quality Systems, Quality Audits, GMP Training Material Development, SOP Development • Biologics: Manufacturing Process, Development of QC Assays, GMP Sterile Fill Manufacturing • Project Management: Timeline Management, Contractor Management, Team Development • Regulatory Submissions (NDA, IND, IMPD, updates) Specialties: CMC Development, Supplier/CMO Management, Quality System Implementation and Management, Regulatory Strategy and Submissions, Validation and Technical Writing
Anymail finder is trusted by tens of thousands of companies to provide accurate contact information to their Sales and Business Development teams.
If you’re looking to find the email of John Lancaster at La Jolla Pharmaceutical then you’ve come to the right place.
Wondering if it's john@ljpc.com, john.lancaster@ljpc.com, lancaster@ljpc.com, or jlancaster@ljpc.com? We have the answers for you.